课题基金 / 基金详情

Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention

Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
批准号:
7355585
负责人:
QING PING DOU
金额:
$23.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-12 至 2011-02-28

项目摘要

项目成果

QING PING DOU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Research has supported proteasome inhibitors as potential novel anticancer drugs and green tea polyphenols (GTPs) as a cancer-preventative agent. We have reported that GTPs, e.g. (-)-epigallocatechin- 3-gallate or EGCG, are potent and specific inhibitors of proteasomal chymotrypsin-like activity (mediated by b5 subunit). Methylation of GTPs, a major biotransformation reaction limiting their cancer-preventative activities in vivo, is mediated by human polymorphic catechol-O-methyltransferase (COMT). The point- mutated COMT, found in -25% of US population, has 3-4-fold decreased enzymatic activity (COMT-LL). It was reported that women tea-drinkers with at least one low activity COMT allele (but not COMT-HH) showed a significantly reduced risk of breast cancer compared with non-tea drinkers, suggesting less protection by methylated polyphenols. To study the responsible mechanism, we hypothesize that O-methylation of GTPs by COMT in breast cancer cells decreases their proteasome-inhibitory and consequently biological activities. This hypothesis is supported by our preliminary results. To further this study, we propose 5 specific Aims. (1) Synthesize O-methylated GTP analogs (by replacing -OH with -OCH3), the deoxy compounds (without the catechol diol), and polyphenol homologs (replacing -OH with -CH2OH) and determine their binding affinity to the proteasomal b5 subunit by employing computational modeling. (2) Evaluate potencies of these synthetic compounds to inhibit the proteasome activity using purified 20S proteasome, breast cancer cell extracts, and intact breast cancer cells. (3) Evaluate the apoptosis-inducing potencies of these synthetic compounds in human breast cancer cells. (4) Determine the effects of over- and under-expression of COMT gene in cultured human breast cancer cells on methylation of GTPs and their proteasome-inhibitory and apoptosis-inducing activities. (5) Determine whether methylation of GTPs is a mechanism to inactivate their biological functions in vivo using nude mice bearing human breast tumor xenografts. These studies should help develop a fundamental understanding about how the polymorphic COMT regulates the biological functions of GTPs in breast cancer cells and the impact of GTP methylation by COMT on the cancer- preventative effects of tea consumption as well as generate important information for designing future cancer prevention clinical trials using GTPs alone or in combination with a COMT inhibitor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
  • 批准号:
    8848363
  • 项目类别:
  • 资助金额:
    $16.53万
  • 财政年份:
    2014
  • 负责人:
    QING PING DOU
  • 依托单位:
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
  • 批准号:
    8685444
  • 项目类别:
  • 资助金额:
    $19.84万
  • 财政年份:
    2014
  • 负责人:
    QING PING DOU
  • 依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
  • 批准号:
    7909204
  • 项目类别:
  • 资助金额:
    $26.33万
  • 财政年份:
    2009
  • 负责人:
    QING PING DOU
  • 依托单位:
The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer
  • 批准号:
    7848072
  • 项目类别:
  • 资助金额:
    $23.72万
  • 财政年份:
    2007
  • 负责人:
    QING PING DOU
  • 依托单位:
海外基金